A composite risk involving compensation burdens and impacts on the business and financial results arising from changes in legal regulations, intellectual property infringement litigation and product liability affecting pharmaceuticals and functional foods. This also includes responding to pharmaceutical-related intellectual property disputes, such as patent litigation in the United States.